PodcastIntel
Sign in Get Started Free
Life Science Connect

CGT Biotech/CDMO Transparency & Core Capabilities

Jul 9, 2026 · 0:10:34
AI Summary
  • CGT developers need transparency and data visibility from CDMOs.
  • Focus on core capabilities over mere capacity in partnerships.
  • CGT companies should retain control over critical aspects.

Guests on This Episode

OK
Omkar Kawalekar
2 podcast appearances
ZZ
Zoe Zheng
2 podcast appearances

More from Life Science Connect

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Life Science Connect and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →